|
|
endocrine system development
|
GO:0035270 |
26 |
0.768
|
Human |
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.730
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
0.729
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.706
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.706
|
Human |
|
|
regulation of heart induction by regulation of canonical wnt signaling pathway
|
GO:0090081 |
1 |
0.688
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
3 |
0.687
|
Human |
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.685
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.676
|
Human |
|
|
cell fate determination
|
GO:0001709 |
3 |
0.611
|
Human |
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.564
|
Human |
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.555
|
Human |
|
|
circulatory system development
|
GO:0072359 |
262 |
0.543
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.543
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.535
|
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.531
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.523
|
Human |
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.522
|
Human |
|
|
hindbrain development
|
GO:0030902 |
3 |
0.522
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.507
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.494
|
Human |
|
|
bmp signaling pathway involved in heart development
|
GO:0061312 |
3 |
0.492
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.490
|
Human |
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.474
|
Human |
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.459
|
Human |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.453
|
Human |
|
|
forebrain development
|
GO:0030900 |
26 |
0.449
|
Human |
|
|
skeletal system development
|
GO:0001501 |
79 |
0.441
|
Human |
|
|
nervous system development
|
GO:0007399 |
293 |
0.436
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.436
|
Human |
|
|
positive regulation of aldosterone metabolic process
|
GO:0032346 |
2 |
0.424
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.412
|
Human |
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.410
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.406
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.403
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.402
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.399
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.393
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.375
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.363
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.340
|
Human |
|
|
brain development
|
GO:0007420 |
97 |
0.331
|
Human |
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.329
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.323
|
Human |
|
|
epithelium development
|
GO:0060429 |
227 |
0.316
|
Human |
|
|
vasculature development
|
GO:0001944 |
181 |
0.316
|
Human |
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.315
|
Human |
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.315
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.302
|
Human |
|
|
head development
|
GO:0060322 |
108 |
0.290
|
Human |
|
|
neurogenesis
|
GO:0022008 |
169 |
0.280
|
Human |
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.280
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.277
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.273
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.270
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.267
|
Human |
|
|
neuron projection development
|
GO:0031175 |
106 |
0.267
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.263
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.260
|
|
|
|
positive regulation of aldosterone biosynthetic process
|
GO:0032349 |
2 |
0.258
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.257
|
Human |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.248
|
Human |
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.245
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.245
|
Human |
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.245
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.242
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.239
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.236
|
Human |
|
|
hormone secretion
|
GO:0046879 |
65 |
0.236
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.233
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.224
|
Human |
|
|
menstrual cycle phase
|
GO:0022601 |
2 |
0.222
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.222
|
Human |
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.218
|
Human |
|
|
heart formation
|
GO:0060914 |
2 |
0.209
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.208
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.205
|
Human |
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.202
|
|
|
|
pancreas development
|
GO:0031016 |
19 |
0.197
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.194
|
Human |
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.191
|
Human |
|
|
secretion
|
GO:0046903 |
254 |
0.190
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.189
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.184
|
|
|
|
system process
|
GO:0003008 |
349 |
0.184
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.184
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.175
|
Human |
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.175
|
Human |
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.173
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.171
|
Human |
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.170
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.168
|
Human |
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.162
|
Human |
|
|
regulation of methylation dependent chromatin silencing
|
GO:0090308 |
3 |
0.157
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.155
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.154
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.154
|
Human |
|
|
spinal cord development
|
GO:0021510 |
4 |
0.152
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.149
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.146
|
|
|
|
canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:0061317 |
3 |
0.145
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.142
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.142
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.141
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.140
|
Human |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.138
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.138
|
|
|
|
positive regulation of tooth mineralization
|
GO:0070172 |
2 |
0.137
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.135
|
Human |
|
|
sensory organ morphogenesis
|
GO:0090596 |
21 |
0.135
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.133
|
|
|
|
oxidative stress induced premature senescence
|
GO:0090403 |
3 |
0.132
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.132
|
|
|
|
soft palate development
|
GO:0060023 |
3 |
0.129
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.127
|
|
|
|
regulation of male gonad development
|
GO:2000018 |
4 |
0.127
|
Human |
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.127
|
Human |
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.122
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.121
|
Human |
|
|
signal release
|
GO:0023061 |
70 |
0.121
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.119
|
Human |
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.117
|
Human |
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.117
|
|
|
|
endodermal mesodermal cell signaling
|
GO:0003133 |
3 |
0.116
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.114
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.113
|
Human |
|
|
mesonephric duct development
|
GO:0072177 |
3 |
0.112
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.112
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.112
|
Human |
|
|
immune system development
|
GO:0002520 |
195 |
0.111
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.111
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.111
|
Human |
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.110
|
Human |
|
|
sex determination
|
GO:0007530 |
3 |
0.109
|
Human |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.108
|
Human |
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.108
|
Human |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.106
|
|
|
|
heart process
|
GO:0003015 |
62 |
0.105
|
|
|
|
negative regulation of testicular blood vessel morphogenesis
|
GO:0061369 |
1 |
0.105
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.105
|
Human |
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.104
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.101
|
Human |
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.101
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.101
|
|
|
|
globus pallidus development
|
GO:0021759 |
1 |
0.099
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.098
|
|
|
|
dermatome development
|
GO:0061054 |
3 |
0.098
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.098
|
Human |
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.098
|
Human |
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.098
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.097
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.096
|
Human |
|
|
positive regulation of steroid hormone biosynthetic process
|
GO:0090031 |
2 |
0.096
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.095
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
43 |
0.095
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.094
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.093
|
Human |
|
|
regionalization
|
GO:0003002 |
29 |
0.093
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.093
|
Human |
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.092
|
Human |
|
|
chromatin modification
|
GO:0016568 |
298 |
0.091
|
Human |
|
|
luteinizing hormone secretion
|
GO:0032275 |
1 |
0.091
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.090
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.090
|
Human |
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.089
|
Human |
|
|
canonical wnt signaling pathway involved in mesenchymal stem cell differentiation
|
GO:0044338 |
2 |
0.089
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.087
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.087
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.087
|
Human |
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.087
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
26 |
0.086
|
Human |
|
|
eye development
|
GO:0001654 |
42 |
0.085
|
Human |
|
|
hard palate development
|
GO:0060022 |
1 |
0.085
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.085
|
|
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.085
|
Human |
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.085
|
|
|
|
growth
|
GO:0040007 |
202 |
0.084
|
Human |
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.083
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.083
|
Human |
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.083
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.083
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.082
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.082
|
Human |
|
|
regulation of system process
|
GO:0044057 |
101 |
0.082
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.082
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.081
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
4 |
0.080
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
4 |
0.080
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.080
|
Human |
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
4 |
0.079
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.078
|
|
|
|
heart field specification
|
GO:0003128 |
2 |
0.078
|
|
|
|
positive regulation of hormone biosynthetic process
|
GO:0046886 |
4 |
0.078
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.078
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.076
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
2 |
0.076
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.075
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.075
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.074
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.074
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.073
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.072
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.072
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
2 |
0.072
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.072
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.072
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.071
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.071
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.071
|
Human |
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.071
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.070
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.070
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.070
|
Human |
|
|
aortic valve development
|
GO:0003176 |
3 |
0.070
|
|
|
|
endoderm formation
|
GO:0001706 |
33 |
0.069
|
Human |
|
|
endoderm development
|
GO:0007492 |
33 |
0.069
|
Human |
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.069
|
|
|
|
mesonephros development
|
GO:0001823 |
17 |
0.068
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.068
|
Human |
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.068
|
Human |
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
1 |
0.067
|
|
|
|
positive regulation of glucocorticoid biosynthetic process
|
GO:0031948 |
1 |
0.067
|
|
|
|
limb bud formation
|
GO:0060174 |
1 |
0.067
|
|
|
|
positive regulation of epithelial cell proliferation involved in wound healing
|
GO:0060054 |
3 |
0.066
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.066
|
|
|
|
canonical wnt signaling pathway involved in osteoblast differentiation
|
GO:0044339 |
2 |
0.066
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.065
|
|
|
|
negative regulation of posttranscriptional gene silencing
|
GO:0060149 |
3 |
0.065
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.064
|
Human |
|
|
somatostatin signaling pathway
|
GO:0038170 |
1 |
0.063
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.063
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.063
|
Human |
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.063
|
Human |
|
|
forebrain neuron development
|
GO:0021884 |
2 |
0.062
|
|
|
|
positive regulation of odontogenesis
|
GO:0042482 |
3 |
0.062
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.062
|
Human |
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.062
|
|
|
|
positive regulation of glucocorticoid secretion
|
GO:2000851 |
4 |
0.061
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.061
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.061
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.061
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.061
|
Human |
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.061
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.060
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.060
|
Human |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.060
|
Human |
|
|
hormone transport
|
GO:0009914 |
68 |
0.059
|
|
|
|
neuroendocrine cell differentiation
|
GO:0061101 |
2 |
0.059
|
|
|
|
positive regulation of glucocorticoid metabolic process
|
GO:0031945 |
1 |
0.059
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.059
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
19 |
0.058
|
|
|
|
positive regulation of cortisol biosynthetic process
|
GO:2000066 |
1 |
0.058
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.057
|
|
|
|
regulation of heart induction
|
GO:0090381 |
2 |
0.057
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.057
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.057
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.057
|
Human |
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.057
|
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.056
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.056
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.056
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.056
|
Human |
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.055
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.055
|
Human |
|
|
regulation of dermatome development
|
GO:0061183 |
3 |
0.055
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.055
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.055
|
Human |
|
|
kidney development
|
GO:0001822 |
53 |
0.055
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.055
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.054
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.054
|
Human |
|
|
muscle contraction
|
GO:0006936 |
73 |
0.054
|
|
|
|
menstruation
|
GO:0042703 |
1 |
0.054
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.054
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.053
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.053
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.053
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.053
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.052
|
Human |
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.052
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.052
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.052
|
Human |
|
|
muscle structure development
|
GO:0061061 |
98 |
0.052
|
|
|
|
bmp signaling pathway involved in heart induction
|
GO:0003130 |
3 |
0.052
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.051
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.051
|
|
|
|
adenylate cyclase inhibiting opioid receptor signaling pathway
|
GO:0031635 |
1 |
0.051
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.051
|
|
|
|
negative regulation of cytosolic calcium ion concentration
|
GO:0051481 |
1 |
0.051
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.051
|
Human |
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.050
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.050
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.050
|
Human |
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.050
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.050
|
Human |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.050
|
Human |
|
|
camera type eye development
|
GO:0043010 |
25 |
0.049
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.049
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.049
|
Human |
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.049
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.049
|
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.049
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.049
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.049
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.049
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.048
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.048
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.048
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.048
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.047
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.047
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.047
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.047
|
Human |
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.046
|
Human |
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.046
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.046
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.046
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.045
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
3 |
0.045
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.045
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.045
|
|
|
|
positive regulation of insulin like growth factor receptor signaling pathway
|
GO:0043568 |
4 |
0.045
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.045
|
|
|
|
right ventricular cardiac muscle tissue morphogenesis
|
GO:0003221 |
2 |
0.045
|
|
|
|
mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003337 |
4 |
0.045
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.045
|
Human |
|
|
central nervous system neuron differentiation
|
GO:0021953 |
9 |
0.044
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.044
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.044
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
13 |
0.044
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.044
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
60 |
0.044
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.044
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.044
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.044
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.043
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.043
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.043
|
Human |
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.043
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.043
|
Human |
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.043
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.043
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
45 |
0.043
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.043
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.043
|
Human |
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.042
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.042
|
Human |
|
|
gastrulation
|
GO:0007369 |
51 |
0.042
|
Human |
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.042
|
Human |
|
|
reproductive process
|
GO:0022414 |
106 |
0.042
|
Human |
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.042
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.041
|
|
|
|
nephron epithelium development
|
GO:0072009 |
23 |
0.041
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.041
|
Human |
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.041
|
|
|
|
negative regulation of gene silencing by rna
|
GO:0060967 |
3 |
0.041
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.041
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.041
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.041
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.040
|
Human |
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.040
|
Human |
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.040
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.040
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.040
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.040
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.040
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.040
|
Human |
|
|
negative regulation of nervous system development
|
GO:0051961 |
28 |
0.040
|
Human |
|
|
metanephros development
|
GO:0001656 |
16 |
0.040
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.040
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.040
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
15 |
0.039
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.039
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
23 |
0.039
|
Human |
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.039
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.039
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.039
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
22 |
0.039
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.039
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.038
|
|
|
|
regulation of organ formation
|
GO:0003156 |
4 |
0.038
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.038
|
Human |
|
|
response to growth factor
|
GO:0070848 |
205 |
0.038
|
Human |
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.038
|
Human |
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.038
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.038
|
Human |
|
|
ureteric bud development
|
GO:0001657 |
13 |
0.037
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.037
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.037
|
|
|
|
bone mineralization
|
GO:0030282 |
34 |
0.037
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.037
|
Human |
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.037
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.037
|
Human |
|
|
metal ion transport
|
GO:0030001 |
272 |
0.037
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.037
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.037
|
Human |
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.036
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.036
|
Human |
|
|
startle response
|
GO:0001964 |
3 |
0.036
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.035
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.035
|
Human |
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.035
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.035
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.035
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.035
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
33 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.035
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.035
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.035
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.035
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.035
|
|
|
|
synaptic transmission
|
GO:0007268 |
61 |
0.034
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.034
|
Human |
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.034
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.034
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.034
|
|
|
|
heart induction
|
GO:0003129 |
4 |
0.034
|
|
|
|
wnt signaling pathway involved in wound healing spreading of epidermal cells
|
GO:0035659 |
1 |
0.034
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.034
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.034
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.034
|
|
|
|
memory
|
GO:0007613 |
3 |
0.034
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
1 |
0.033
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.033
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.033
|
Human |
|
|
pulmonary vein morphogenesis
|
GO:0060577 |
1 |
0.033
|
|
|
|
axonogenesis
|
GO:0007409 |
31 |
0.033
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.033
|
|
|
|
positive regulation of dermatome development
|
GO:0061184 |
3 |
0.033
|
|
|
|
negative regulation of gene silencing by mirna
|
GO:0060965 |
3 |
0.033
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.033
|
Human |
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.033
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.033
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.033
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.033
|
Human |
|
|
blood vessel maturation
|
GO:0001955 |
1 |
0.032
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.032
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
46 |
0.032
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.032
|
Human |
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
1 |
0.032
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.032
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.032
|
|
|
|
endodermal cell differentiation
|
GO:0035987 |
31 |
0.032
|
Human |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.032
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.032
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.032
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.032
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.032
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
4 |
0.032
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.032
|
Human |
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.032
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.032
|
Human |
|
|
peptide secretion
|
GO:0002790 |
51 |
0.032
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.031
|
Human |
|
|
cd8 positive alpha beta t cell differentiation involved in immune response
|
GO:0002302 |
1 |
0.031
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.031
|
|
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
3 |
0.031
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.031
|
Human |
|
|
negative regulation of wnt protein secretion
|
GO:0061358 |
1 |
0.031
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.031
|
Human |
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.031
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.031
|
|
|
|
cell aggregation
|
GO:0098743 |
1 |
0.031
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.031
|
Human |
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.031
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.031
|
Human |
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.031
|
Human |
|
|
nerve development
|
GO:0021675 |
4 |
0.031
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.031
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.031
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.031
|
Human |
|
|
endodermal mesodermal cell signaling involved in heart induction
|
GO:0003134 |
3 |
0.031
|
|
|
|
renal tubule development
|
GO:0061326 |
19 |
0.031
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.030
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.030
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
15 |
0.030
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.030
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.030
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.030
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.030
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.030
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.030
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.030
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.030
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.030
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.030
|
Human |
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.030
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.030
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.030
|
|
|
|
neural crest cell migration
|
GO:0001755 |
2 |
0.029
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.029
|
|
